Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from PharmaCielo

PharmaCielo Cannabis Co. Reports 270% YoY Increase In Q3 Revenue, Confident About Profitability In 2025

Cannabis products company PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) announced on Monday financial and operational results for the three and nine months ended Sept. 30, 2024. The Toronto-based company said revenue for the third quarter totaled CA$1.3 million ($927,772), up from CA$352,000 in the prior year's period. For the nine…

Benzinga · Dec 2, 2024

PharmaCielo Q3 Revenue Stagnates, What About Adjusted EBITDA?

PharmaCielo Ltd. (TSXV:PCLO) (OTCQX: PCLOF), released financial results for the third quarter ended September 30, 2022, revealing total revenue of CA$475,323 ($348,000), a 2% decrease compared to CA$485,165 in Q3 2021.

Benzinga · Oct 31, 2022

Update On Cannabis M&A: Aurora, TerrAscend, SNDL, Curaleaf, And… A Costly Preferred Stock Raise?

On Thursday, analyst Pablo Zuanic from Cantor Fitzgerald offered an industry update on four recent M&A deals and Glasshouse Series B Preferred stock issuance.

Benzinga · Sep 2, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

PharmaCielo Q2 Revenue Soars 375% YoY, Raises Additional $4.6M In Oversubscribed Debenture Financing

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) Q2 2022 revenue was CA$2.1 million, a 375% increase compared to CA$446,000 in Q2 2021.

Benzinga · Aug 31, 2022

Strategic Cannabis Execs Making Changes At Companies You Know: PharmaCielo, Willow Industries, Delta 9 & More

As Benzinga Cannabis Capital Conference returns (September 13-14) to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the space.

Benzinga · Aug 1, 2022

PharmaCielo Ships CBD Full Spectrum Oil To A Brazilian Pharmaceutical Company

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., shipped an initial shipment of a CBD full spectrum extract with THC content

Benzinga · Jun 6, 2022

PharmaCielo Q1 Revenue Increases 77.92% YoY, Discusses International Markets

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) Q1 2022 revenue was CA$1.2 million ($947,000) compared to CA$675,000 in Q1 2021, an increase of 77.92%.

Benzinga · May 31, 2022

Read news from The Economist, FT, and more,
with one subscription

PharmaCielo Enters Spanish Market With Initial Shipment Of 300Kg Of CBD Full Spectrum Oil To Extractions Solutions

PharmaCielo Ltd.

Benzinga · May 24, 2022

PharmaCielo To Enter Polish Medical Cannabis Market Via Partnership With Soteria Holdings

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) parent of PharmaCielo Colombia Holdings S.A.S, has signed an investment agreement with Soteria Holdings Limited.

Benzinga · May 6, 2022

PharmaCielo Cuts Net Loss By 39.13% To $20.9M Despite Plummeting Revenues In 2021

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., announced financial results for the fourth quarter and year ended December 31, 2021

Benzinga · Apr 29, 2022

Colombia's Flora Growth & PharmaCielo Begin Exporting Dried Flower As New Rules Take Effect

Colombian cannabis companies are now able to export THC and CBD-dried flower. The government's completion of a regulatory checklist will essentially enable such cannabis companies as Flora Growth (NASDAQ:FLGC) and PharmaCielo (TSXV:PCLO) (OTCQX:PCLOF) to export to the United States and numerous other countries. The announcement follows the government's passing of Regulation 227 in February, which was designed to make the country's…

Benzinga · Apr 4, 2022

PharmaCielo Inks First THC Sales Agreement, Will Supply Germany Via Greenstein And NOWEDA

PharmaCielo (OTCQX: PCLOF) will start supplying the German market with three THC-dominant products, with commercial shipments expected to begin in late 2022.

Benzinga · Feb 15, 2022

Coverage From

Benzinga

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Benzinga Cannabis Capital Conference

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.